Gene Network Sciences will use its Reverse Engineering/Forward Simulation technology in its collaboration with the University of Texas M.D. Anderson Cancer Center to identify genes and proteins linked to the development of glioblastoma. Findings from the research will be used to identify therapeutic targets for the common type of brain cancer, the company said.

Related Summaries